Abstract

Many pathogenic Candida species possess the ability to undergo a reversible morphological transition from yeast to filamentous cells. In Candida albicans, the most frequently isolated human fungal pathogen, multiple lines of evidence strongly suggest that this transition is associated with virulence and pathogenicity. While it has generally been assumed that non-albicans Candida species (NACS) are less pathogenic than C. albicans, in part, because they do not filament as well, definitive evidence is lacking. Interestingly, however, a recent study suggests that filamentation of NACS is associated with reduced, rather than increased, pathogenicity. These findings, in turn, challenge conventional views and suggest that there are fundamental evolutionary differences in the morphology–pathogenicity relationship in C. albicans vs. NACS. The findings also raise many new and intriguing questions and open new avenues for future research, which are discussed.

Highlights

  • Candida species represent the fourth leading cause of hospital-acquired bloodstream infections in the U.S [1,2]

  • 50% of all Candida infections can be attributed to C. albicans, the most frequently isolated human fungal pathogen, while the remainder are caused by the less pathogenic non-albicans

  • In order to more precisely define the relationship between the yeast–filament transition and pathogenicity in non-albicans Candida species, Banerjee et al have recently carried out a study using C. tropicalis and C. parapsilosis tetO-UME6 strains genetically engineered to switch from yeast to filamentous form [49]

Read more

Summary

Introduction

Candida species represent the fourth leading cause of hospital-acquired bloodstream infections in the U.S [1,2]. Early work showed that C. albicans strains locked in either the yeast or filamentous form were highly attenuated for virulence in a mouse model of systemic candidiasis [28,29,30].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call